References
- Thalèn A, Brattsand R. Synthesis and anti inflammatory properties of budesonide, a new non halogenated glucocorticoid with high local activity. Arnzeim. Forsch./Drug Res 1979; 29: 1687–90
- Gruvstad E, Bengtsson B A. Comparison of a new steroid, budesonide, with other topical corticosteroids in the vasoconstriction assay. Drugs Exp Clin Res 1980; 65: 385–90
- Agrup G, Björnberg A, Elmros T, et al. Clinical trial of a potent non halogenated topical steroid, budesonide. Acta Derm Venereol (Stockh) 1981; 61: 180–2
- Scott M, Malmsten L A, Thelin I, et al. Effect on plasma cortisol level and urinary cortisol excretion in healthy volunteers, after application of three different topical steroid ointments under occlusion. Acta Derm Venereol (Stockh) 1981; 61: 543–6
- Salde L, Schröpl F. Effect of budesonide 0.025% cream on plasma cortisol levels in healthy volunteers. Curr Ther Res 1983; 33: 53–6
- Anderson P, Edsbäcker S, et al. In vitro biotransformation of glucocorticoids in liver and skin homogenate fraction from man. rat and hairless mouse. J Steroid Biochem 1982; 16: 787–95
- Fredriksson T, Salde L. A double-blind trial in budesonide and betamethasone 17,21-dipropionate in psoriasis. Curr Med Res Opin 1982; 8: 171–7
- Degreef H, Salde L. A double blind comparative trial of budesonide 0.025% ointment and betamethasone 17.21-dipropionate 0.05% ointment in psoriasis. Curr Ther Res 1981; 29: 880–4
- Schmidt H, Hjorth N, Salde L, et al. A double blind trial of budesonide ointment and betametasone 17-valerate ointment in psoriasis. J Int Med Res 1981; 9: 236–8
- Lassus A, Salde L. A double blind comparison of two topical steroids in psoriasis and eczemas: budesonide 0.025% ointment and betamethasone 17-valerate 0.1% ointment. Pharmatherapeutica 1981; 2: 668–72
- Heyer A, Hesser G, Holm P, et al. Comparison between two non halogenated glucocorticoid ointments in psoriasis. J Int Med Res 1981; 9: 239–47
- Dijk V E, Starink Th M, Tsllefsrud A, et al. Treatment of psoriasis with non halogenated glucocorticosteroids. Curr Ther Res 1982; 31: 645–9
- Salde L, Schröpl F. Budesonid - ein potentes nichtfluoriertes Derivat aus der neuen Generation topisch wirksdmer Steroide. Z Hautkr 1982; 57: 1745–54